|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |
| Depreciation and amortization | |
| Non-cash operating lease costs | |
| Stock-based compensation, net of amounts capitalized | |
| Amortization of deferred commissions | |
| Net accretion of discounts on available-for-sale securities | |
| Unrealized (gains) losses on equity investments, net | |
| Other non-cash adjustments | |
| Changes in assets and liabilities: | |
| Accounts receivable, net | |
| Prepaid expenses and other current assets | |
| Other assets | |
| Accounts payable | |
| Accrued and other current liabilities | |
| Accrued compensation and benefits | |
| Deferred revenue | |
| Other non-current liabilities | |
| Net cash provided by (used in) operating activities | |
| Cash flows from investing activities: | |
| Purchase of intangible assets | |
| Capital expenditures | |
| Capitalized internal-use software development costs | |
| Cash paid for business combinations, net of cash acquired | |
| Purchases of marketable securities | |
| Proceeds from maturities of marketable securities | |
| Proceeds from sale of marketable securities | |
| Proceeds from sale of digital assets | |
| Purchases of digital assets | |
| Other cash flows from investing activities | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Repurchase of common stock | |
| Payment of deferred offering costs, net of costs reimbursed | |
| Cash paid for issuance costs on revolving credit facility | |
| Proceeds from options exercised | |
| Proceeds from issuance of common stock under employee stock purchase plan | |
| Proceeds from issuance of common stock | |
| Proceeds from borrowings under revolving credit facility | |
| Repayments on borrowings under revolving credit facility | |
| Proceeds from initial public offering, net of underwriting discounts and commissions | |
| Taxes paid related to net share settlement of equity awards | |
| Proceeds from sale of common stock in connection with May 2024 RSU release primary financing | |
| Other cash flows from financing activities | |
| Net cash provided by financing activities | |
| Change in cash, cash equivalents, and restricted cash | |
| Cash, cash equivalents, and restricted cash—beginning of period | |
| Cash, cash equivalents, and restricted cash—end of period | |
| Supplemental cash flow data: | |
| Cash paid during the period for income taxes, net of refunds: | |
| Federal | |
| State | |
| Foreign | |
| Israel | |
| Other | |
| Total cash paid during the period for income taxes, net of refunds | |
| Payments for operating leases included in cash from operating activities | |
| Operating lease right-of-use assets obtained in exchange for lease liabilities | |
| Non-cash investing and financing activities: | |
| Stock-based compensation included in capitalized internal-use software development costs | |
| Fair value of shares issued in connection with business combination | |
| Conversion of convertible preferred stock to common stock upon initial public offering | |
| Reclassification of deferred offering costs to additional paid-in capital upon initial public offering | |
| Reconciliation of cash, cash equivalents and restricted cash: | |
| Cash and cash equivalents | |
| Restricted cash, including restricted cash in prepaid expenses and other current assets |
Loading...
